Cost-Effectiveness, Efficacy, and Safety Analysis of Tailored Therapy in Patients with <i>Helicobacter pylori</i> Infection

Recently in Korea, where triple therapy is accepted as the first-line <i>Helicobacter pylori</i> (<i>H. pylori</i>) eradication treatment, antibiotic resistance to clarithromycin has increased considerably, resulting in eradication rates of less than 80%. We investigated the...

Full description

Bibliographic Details
Main Authors: A Reum Choe, Ki-Nam Shim, Yehyun Park, Eun-Mi Song, Chung Hyun Tae, Sung-Ae Jung
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/12/2619